-
1دورية أكاديمية
المؤلفون: Frank Kowalzik, Daniel Teschner, Margarida Mesquita, Christian Jensen, Daniel Schreiner, Kai Kronfeld, Marija Tubic-Grozdanis, Darline Cheatham-Seitz, Franziska Hettich, Gianluca Quintini, Oliver Schoenborn-Kellenberger, Paula Codó, Philipp von Eisenhart-Rothe, Philipp Mann, Lidia Oostvogels, Stephan Gehring
المصدر: Vaccine: X, Vol 19, Iss , Pp 100512- (2024)
مصطلحات موضوعية: CVnCoV, SARS-CoV-2, mRNA, Vaccine, Covid-19, Healthcare workers, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: Ana Ascaso-del-Rio, Javier García-Pérez, Mayte Pérez-Olmeda, Eunate Arana-Arri, Itziar Vergara, Carla Pérez-Ingidua, Mercedes Bermejo, María Castillo de la Osa, Natale Imaz-Ayo, Ioana Riaño Fernández, Oliver Astasio González, Francisco Díez-Fuertes, Susana Meijide, Julio Arrizabalaga, Lourdes Hernández Gutiérrez, Humberto Erick de la Torre-Tarazona, Alberto Mariano Lázaro, Emilio Vargas-Castrillón, José Alcamí, Antonio Portolés
المصدر: EClinicalMedicine, Vol 51, Iss , Pp 101542- (2022)
مصطلحات موضوعية: COVID-19 vaccines, mRNA vaccines, Heterologous vaccination, BNT162b2, CVnCoV, Fourth dose, Medicine (General), R5-920
وصف الملف: electronic resource
-
4
المؤلفون: Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, Gabriella Santilli, Martina Zappa, Paolo Verdecchia
مصطلحات موضوعية: Ad26.COV2.S, CVnCoV, hypertension, ChAdOx1nCoV-19, adverse drug reaction, blood pressure, COVID-19, NVX-CoV2373, mRNA-1273, vaccine, Pharmacology (medical), BNT162b2, Gam-COVID-Vac, General Pharmacology, Toxicology and Pharmaceutics
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7287974f8f60ce755a0c23bd8bc23a
http://hdl.handle.net/11383/2136464 -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6
المؤلفون: Christine M. Akamine, Hana M. El Sahly
المصدر: Translational Research
مصطلحات موضوعية: PAMPs, Pathogen-associated molecular patterns, COVID-19 Vaccines, MERS-CoV, Middle east respiratory syndrome coronavirus, CVnCOV, CureVac, VOC, Variants of concern, Review Article, BMI, Body mass index, COVID-NET, COVID-19-Associated Hospitalization Surveillance Network, DCs, Dendritic cells, EUA, Emergency use authorization, mRNA, Messenger ribonucleic acid, dsRNA, Double-stranded RNA, GMC, Geometric mean concentration, Physiology (medical), SAM, Self-amplifying mRNA, COVID-19, Coronavirus disease of 2019, Humans, LNP, Liposomal nanoparticle, CDC, Centers for Disease Control, RNA, Messenger, Ad5, Adenovirus type 5, ACE-2, Angiotensin converting enzyme receptor, Pandemics, BNT162 Vaccine, B.1.1.7, Alpha variant, MHC, Major histocompatibility complex, Vaccines, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, B.1.351, Beta variant, SARS-CoV-2, Biochemistry (medical), Public Health, Environmental and Occupational Health, COVID-19, General Medicine, FDA, Food and Drug Administration, GMT, Geometric mean titer, BAU, binding antibody units, APCs, Antigen presenting cells, UTR, Untranslated regions, VAERS, Vaccine adverse event reporting system, RBD, Receptor-binding domain
-
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Sáez-Llorens X; Cevaxin, The Panama Clinic, Panama City, Panama., Lanata C; Instituto de Investigación Nutricional, Lima, Peru., Aranguren E; Cevaxin, The Panama Clinic, Panama City, Panama., Celis CR; Cevaxin, The Panama Clinic, Panama City, Panama., Cornejo R; Instituto de Investigación Nutricional, Lima, Peru., DeAntonio R; Cevaxin, The Panama Clinic, Panama City, Panama., Ecker L; Instituto de Investigación Nutricional, Lima, Peru., Garrido D; Cevaxin, The Panama Clinic, Panama City, Panama., Gil AI; Instituto de Investigación Nutricional, La Molina, Peru., Gonzales M; CureVac AG, Tübingen, Germany., Hess-Holtz M; Cevaxin, The Panama Clinic, Panama City, Panama., Leroux-Roels G; Ghent University Hospital, Ghent, Belgium., Junker H; CureVac AG, Frankfurt, Germany., Kays SK; Ghent University Hospital, Ghent, Belgium., Koch SD; CureVac AG, Tübingen, Germany., Lazzaro S; CureVac AG, Tübingen, Germany., Mann P; CureVac AG, Frankfurt, Germany., Quintini G; CureVac AG, Tübingen, Germany., Srivastava B; CureVac AG, Tübingen, Germany., Vahrenhorst D; CureVac AG, Tübingen, Germany., von Eisenhart-Rothe P; CureVac AG, Tübingen, Germany., Wolz OO; CureVac AG, Tübingen, Germany., Oostvogels L; CureVac AG, Frankfurt, Germany.
المصدر: Vaccine: X [Vaccine X] 2022 Aug; Vol. 11, pp. 100189. Date of Electronic Publication: 2022 Jul 01.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-1362 (Electronic) Linking ISSN: 25901362 NLM ISO Abbreviation: Vaccine X Subsets: PubMed not MEDLINE